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Since the first transgenic crop was released in in the 
world in 1994, cultivation of several varieties has grown 
rapidly to reach 175 million hectares, more than 10% of 
the world’s arable land, in 27 countries.  Adoption and 
commercialization of transgenic products is growing by 
3% per year in developed and developing countries.  There 
is ample evidence that application of transgenic products 
significantly increases crop productivity and food nutrition 
and provides higher net financial and environmental 
benefits. Furthermore, after 20 years of consumption, the 
products are as safe as any other food.
Transgenic research in CGIAR centres in Africa 
In the last ten years, CGIAR centres have invested 
substantially in biotechnology and subsequently in 
transgenic research in terms of physical infrastructure, 
state of the art equipment, and competent human capacity.  
They now have the physical capacity to carry out a range 
of biotechnology research from genomics and genetic 
engineering to field testing of transgenic crops under all 
safety and environmental contexts. 
Funding for such transgenic research in CGIAR is limited 
to a few mainly bilateral or philanthropic donors and there 
has not been an active search for funds from multilateral 
donors or the private sector.  This situation is at least 
partly due to the lack of a coherent and strong voice at the 
CGIAR level in favor of using transgenic technologies to 
develop and release biotech products.
Nonetheless, centres are carrying out a considerable 
number of transgenic research activities that have a 
potential to contribute to food security and nutrition in 
Africa. In line with their mandates, they are working on 
insect resistance, disease resistance, drought resistance, 
nutrient efficiency and bio-fortification. Most of the 
gene constructs used by the centres are developed 
by themselves using elements from the private sector 
or advanced research institutions. They are generally 
royalty-free. Some centres are developing their own 
gene constructs for identified priority traits. In this area, 
however, they are still perceived by policymakers and a 
section of the public in Africa to be promoting the interests 
of multinational companies rather than poor farmers. 
So far, no CGIAR centre has released a transgenic product 
for commercialization in Africa. There has been laboratory 
and field testing of transgenic cassava, maize, cotton, banana 
and potato for the last five to 10 years and products 
are expected to be ready for release and subsequent 
commercialization and adoption by farmers in the next 
two to three years. While the centres are posed to transfer 
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transgenic technologies to national partners for release 
of biotech products in the next few years, weaknesses 
in communications, interactions with policymakers and 
partnerships with regional, sub-regional and national 
research hamper deployment and commercialization. 
Regarding livestock transgenic research, there is only one 
project at the International Livestock Research Institute 
(ILRI) on trypanosomiasis resistance in cattle. Unlike crops, 
there is very little funding for livestock transgenic research 
and this single research activity at ILRI may not have 
adequate funding to reach the ultimate conclusion.
Transgenic research in national and regional institutes 
In the last decade, Africa has established relatively strong 
regional and sub-regional organizations in agricultural 
research, dealing with advocacy, policy development and 
coordination of research activities. Organizations like the 
Forum for Agricultural Research in Africa (FARA) and its 
sub-regional member associations are becoming major 
players in agricultural research for development and they 
attract reasonable donor support for advocacy, policy and 
agenda-setting.  These organizations have identified the 
lack of human capacity, lack of funding and a non-conducive 
policy environment as the main impediments for transgenic 
research and product deployment in Africa.
Others institutes such as the African Agricultural 
Technology Foundation (AATF) and the ILRI-Biosciences 
East and Central Africa (BecA) Hub are key players in 
technology brokerage and they provide access to modern 
bioscience infrastructure for transgenic research in Africa.
All African countries except three have ratified the 
Cartagena Protocol on Biosafety in the Convention 
on Biodiversity Conservation. The protocol sets the 
international framework by which governments could 
develop their own biotechnology policies, biosafety 
legislation and regulations. While progress has been slow, 
a critical mass of African countries now has national 
policies, legislation and, in some cases, regulations to enable 
transgenic research and the deployment of its products. 
Policymakers seem well aware of the advantages and 
concerns of GMOs. Generally, countries that have not 
made much progress with biotechnology policies and 
biosafety legislation are constrained by lack of capacity, 
pressure from anti-GMO activists and lack of political will. 
Out of the 12 countries researched for this study, eight 
have biotechnology policies and biosafety legislation in 
place, two have biotechnology policies and are at advanced 
stages of legislating biosafety bills and two have neither a 
biotechnology policy nor a biosafety bill.  All 12, except 
those countries without biosafety policies, have established 
mechanisms and institutions to regulate biotechnology 
research and the deployment of transgenic products. But 
some may not have the capacity necessary to carry out the 
regulatory function effectively.
Definitions
Transgenic research is part of the science of biotechnol-
ogy. Biotechnology is ‘any technological application that 
uses biological systems, living organisms or derivatives 
thereof to make or modify products or processes for use’.  
Agricultural biotechnology is any technology application 
that uses biological systems, living organisms or derivatives 
thereof to make or modify products or processes for use 
in agriculture (crops, livestock, fisheries and trees).  
Genetic engineering is the group of techniques used 
to cut up and join genetic material especially the DNA 
from one or more species for introduction to an organ-
ism in order to change one or more of its characteris-
tics. It is the process of creating new gene constructs for 
a desired trait and is commonly referred to as ‘modifying 
genotypes, hence phenotypes by transgenesis’1. 
Transgenesis is the process of introducing an exogenous 
gene either from an unrelated or related organism into 
a living organism so the organism exhibits new proper-
ties and transmits those properties to its offspring. It 
introduces a ‘gene or genes into animal or plant cells 
which leads into transmission of input gene (transgene) 
into successive generations’1. 
Transgenic research starts from the science of genomics 
which applies DNA sequencing methods and bioinfor-
matics to sequence, assemble and analyse the function 
and structure of genomes so as to better understand all 
genes and their interrelationships in order to identify their 
combined influence on the growth and development of the 
organism. Genomics provides the information required for 
genetic engineering and gene discovery for desired traits. 
Once genes have been discovered and gene constructs 
constituted for a desired trait, organisms are genetically 
transformed to acquire the traits through transgenesis. 
The products of transgenesis are commonly referred 
to as genetically modified organisms (GMOs). Trans-
genic products result from new knowledge of the 
genome, functional analysis and genetic engineering 
or genetic transformation for desirable traits in plants 
and animals. 
________________
FAO. 2013. Biotechnologies for Agricultural Development: Agricultural 
Biotechnology in Developing Countries. Rome: FAO. www.fao.org/biotech/
biotechnology-glossary
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Many of these countries have the critical mass of physical 
infrastructure needed for transgenic research, in terms 
of buildings for laboratories and offices. However, they 
lack equipment and technical staff.  The most serious 
constraints for transgenic research in Africa are the lack of 
scientific capacity, lack of funds and the threat of anti-GMO 
activists. While some of the countries have some scientists 
able to partner with CGIAR centres on adaptive transgenic 
research, only South Africa has the scientists able to take 
part in basic transgenic research activities. 
Despite the lack of human capacity and financial resources, 
transgenic research activities are taking place in nine out 
of the 12 countries. They are generally led by CGIAR 
centres, with a few by the private sector. Except in South 
Africa, there is no real investment in transgenic research 
by national governments and all research activities are 
supported by donors and the private sector. 
Unlike crops, livestock transgenic research in Africa is 
very weak. The policies and legislation in place do not 
seem to cater for transgenic livestock research and 
deployment of livestock transgenic animals. Except in 
Kenya and South Africa, policymakers and lawmakers do 
not anticipate a role for transgenic livestock research 
and products in livestock productivity. There is neither 
the physical nor the human capacity to undertake 
or participate in transgenic livestock research in the 
countries in this study.  The policymakers see this type 
of research as too advanced for their meagre human 
capacity and the national research systems have no 
plans to undertake this type of research in the near 
future.
The most critical barriers to transgenic research and the 
application of biotechnology tools in Africa are (i) lack of 
scientific capacity to carry out transgenic research and 
communicate results to farmers and policymakers; (ii) lack 
of financial resources not only for transgenic research but 
also for agricultural research and development in general; 
(iii) inadequate policies, legislation and regulations to guide 
biotechnology and consequently transgenic research and 
development; (iv) inadequate capacities and inefficiencies of 
regulatory institutions responsible for transgenic research; 
(v) ambivalent political positions on research, adoption, 
commercialization and consumption of GMOs and (vi) anti-
GMO lobbying by civil society. 
India’s experience and progress in transgenic research 
provides very useful lessons for African countries. Unlike 
Africa, India has an immense human and physical capacity 
in transgenic research accumulated over time. India is also 
investing substantially in transgenic research to position 
itself to be a major global player.  As in Africa, despite this 
tremendous experience, only one trangenic crop has been 
released in India but several others are in the pipeline. 
India also has active anti-GMO lobby groups which 
challenge transgenic research and deployment, even in 
courts. So far, the research system in India is not deterred 
or distracted.
Vision and objectives for transgenic 
research in Africa 
Within CGIAR, the strategic vision of transgenic research 
is derived from a CGIAR Strategic Results Framework. 
The vision of CGIAR focuses on reduction of poverty 
and hunger, improvement of health and nutrition, and 
ecosystems resilience through high quality international 
agricultural research, partnerships and leadership. 
Aligning to this, a vision of transgenic research for CGIAR 
centres is ‘to increase crop and livestock productivity and 
quality for wealth creation, food and nutrition security, 
and ecosystem quality in Africa through transgenic 
biotechnology research, partnerships and leadership.’
Since transgenic research is a relatively new tool and is a 
small component of the research portfolio of CGIAR, the 
contribution of transgenic products to the vision of CGIAR 
is expected to be small, but strategic and impact-driven. 
The strategic focus for transgenic research by CGIAR 
centres should be institutional support development and 
implementation of research activities, capacity development and 
creating an enabling environment for deployment, stewardships, 
commercialization and adoption of transgenic technologies by 
resource-poor farmers. Transgenic research by CGIAR centres 
in Africa should embrace the following objectives:
•	 Improve planning, implementation efficiency, policy 
and communication of transgenic biotechnology 
research in Africa.
•	 Develop crop varieties with novel traits for increased 
productivity, economic benefits and nutritional value.
•	 Develop livestock breeds with novel traits for 
increased productivity and economic benefits.
•	 Build capacity in national agricultural research 
systems for transgenic research and services in Africa.
•	 Enhance the deployment, stewardship, 
commercialization and adoption of transgenic 
products in Africa. 
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Strategic process and actions 
To achieve these objectives, centres and partners need to 
adapt the following new strategic processes and actions to 
support transgenic agricultural research in Africa:
Institutional support
•	 Establish a CGIAR biotechnology strategy support, 
planning and oversight group.
•	 Review institutional biotechnology policies in 
consultation with partners.
•	 Jointly communicate and interact with public and 
policymakers on transgenic products.
•	 Jointly review and plan transgenic field research 
activities.
•	 Mainstream regional advocacy, biosafety capacity 
building, policy and baseline activities into regional 
and sub-regional organizations.
Crops research
•	 Enhance support to ongoing transgenic research 
activities in Africa to release and commercialise 
products.
•	 Diversify donor funding for transgenic research in 
Africa.
•	 Deploy transgenic research products of orphan food 
crops being developed by centres to Africa.
•	 Develop a program for bio-fortified rice for Africa.
•	 Develop binding partnerships with regional and sub-
regional organizations to be their agents for basic 
transgenic research and implementation.
Livestock research
•	 Enhance the ongoing research on trypanosomiasis 
resistance in cattle for Africa.
•	 Revamp basic (genomics and sequencing) livestock 
biotechnology research for gene discovery.
•	 Initiate transgenic livestock research for novel traits 
into small ruminants and poultry.
Capacity development
•	 Mainstream capacity building for national agricultural 
research systems into ongoing transgenic research 
activities.
•	 Develop and support training needs assessment 
for biotechnology research in national agricultural 
research systems.
•	 Develop and support training and capacity training 
programs in partnership with national agricultural 
research systems and universities.
•	 Support regional bioscience research and capacity 
building entities in Africa. 
•	 Develop South-South cooperation programs 
between the national agricultural research systems 
and sub-regional organizations in Africa.
Deployment, stewardship, commercialization and 
adoption of transgenic products
•	 Mainstream field trials, release and stewardship 
of transgenic products into national agricultural 
research systems and the private sector in best-bet, 
ready countries.
•	 Strengthen partnerships between centres and 
national agricultural research systems and the private 
sector for release and stewardship of transgenic 
products. 
•	 Participate in regional, sub-regional and national 
policy and communication fora.
•	 Mainstream release and commercialization, 
intellectual property and trade related issues in 
transgenic research programs.
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